Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy

Technology appraisal guidance
Reference number: TA323
Published: 26 November 2014

Evidence

Supporting evidence

Review decision
Review decision – April 2018
Review decision paper (PDF 138 KB)

Published:

26 April 2018